Dementia Symposium 2017


Illuminating the Journey
Research Knowledge Practice

Dementia

Symposium

2017

Thank you to everyone who participated in Illuminating the Journey: Dementia Symposium 2017. A diverse audience engaged with our presenting panelists to explore leading research related to the diagnosis, prevention, and treatment of Alzheimer’s and dementia related diseases. For those interested in further exploring the research presented, we have provided links to the full presentations below.

Check back soon for future research and education events presented by Gordie Howe Center for Research and Education Society.

Featuring Renowned Physician Researchers

Featuring Renowned Physician Researchers

Dr. Michael Borrie

M.D. ChB, FRCPC

Michael Borrie, MB ChB, FRCPC is a Geriatrician and Professor in the Department of Medicine, Division of Geriatric Medicine, The University of Western Ontario.His research interests include predictors of conversion from mild cognitive impairment (MCI) to Alzheimer Disease (AD), including sensitive Neuroimaging techniques, and randomized controlled trials of new treatments for MCI and AD.

Dr. David Howe

M.D. D.C., M.B.A

David A. Howe, M.D. D.C., M.B.A. is the Chief Executive and Medical Officer of Longevity Medicine. He has championed the design, development and implementation of solutions related to the advancement of stem cell technology and has contributed significantly to all critical processes. Dr. Howe is the Medical Monitor for the Gordie Howe Traumatic Brain Injury Stem Cell Study.

Dr. Zahinoor Ismail

M.D. FRCPC

Zahinoor Ismail M.D. FRCPC is Assistant Professor of Psychiatry and Neurology, Hotchkiss Brain Institute. Dr. Ismail’s research interests revolve extensively around the interface between cognition and neuropsychiatric symptoms including studies of clinical psychopharmacology, adverse drug reactions/drug interactions, epidemiology, cognitive screening and neuroimaging biomarkers of neuropsychiatric illnesses.